Peter Ruminski

3.0k citations

46 papers · 2.5k · 1 hit paper · h-index 19

Impact in

Immunology and Allergy top 2%
- Cell Adhesion Molecules Research
Hepatology top 5%
- Liver physiology and pathology

Papers in

Immunology and Allergy 7
- Cell Adhesion Molecules Research 7
Hematology 8
- Hematopoietic Stem Cell Transplantation 6

Co-authors: David W. Griggs (11 shared papers)Michael J. Prinsen (4 shared papers)Steven L. Settle (4 shared papers)Christer Betsholtz (1 shared paper)Antonella Pellicoro (1 shared paper)Neil Cowan Henderson (3 shared papers)Ralf H. Adams (2 shared papers)Juan Duque Rodríguez (1 shared paper)
Journals: Blood (3 papers)Bioorganic & Medicinal Chemistry (3 papers)Journal of Clinical Investigation (3 papers)Blood Advances (2 papers)Organic Process Research & Development (2 papers)
Partner nations: United States United Kingdom South Africa

In The Last Decade

Peter Ruminski

45 papers receiving 2.4k citations

Peter Ruminski's Hit Papers

align trajectories log scale

Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs 2013 · 730 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2013 Nature Medicine

Peers

Countries citing papers authored by Peter Ruminski

Since Specialization

Citations

This map shows the geographic impact of Peter Ruminski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ruminski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ruminski more than expected).

Fields of papers citing papers by Peter Ruminski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Ruminski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ruminski. The network helps show where Peter Ruminski may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Ruminski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Ruminski Line = papers co-authored together Peter Ruminski links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs Nature Medicine ·Neil Cowan Henderson, Thomas D. Arnold, Yoshio Katamura, Marilyn M. Giacomini, Juan Duque Rodríguez, Joseph H. McCarty, Antonella Pellicoro, Elisabeth Raschperger Hit paper breakdown →	2013	730
2	Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo The Journal of Experimental Medicine ·Mahesh Chandra Yadav, Cédric Louvet, Dan W. Davini, James Morgan Gardner, Marc Martínez‐Llordella, Samantha L. Bailey-Bucktrout, Bryan A. Anthony, Francis M. Sverdrup	2012	557
3	A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. Journal of Clinical Investigation ·V. Wayne Engleman, G. Allen Nickols, F. Patrick Ross, Maya A Horton, David W. Griggs, Steven L. Settle, Peter Ruminski, Steven L. Teitelbaum	1997	262
4	Suppression of the fibrotic encapsulation of silicone implants by inhibiting the mechanical activation of pro-fibrotic TGF-β Nature Biomedical Engineering ·Nina Noskovičová, Ronen Schuster, Sander van Putten, Maya Ezzo, Anne B. Koehler, Stellar Boo, Nuno M. Coelho, David W. Griggs	2021	134
5	αv integrins on mesenchymal cells regulate skeletal and cardiac muscle fibrosis Nature Communications ·Iain Robert Murray, Zaniah N. Gonzalez-Galofre, Johanna L. Baily, Ross Dobie, Robert James Wallace, Alison C. MacKinnon, James R. Smith, Stephen N. Greenhalgh	2017	89
6	Anti-metastatic properties of RGD-peptidomimetic agents S137 and S247 Clinical & Experimental Metastasis ·Kristen E. Shannon, Jeffery L. Keene, Steven L. Settle, Tiffany D. Duffin, Maureen A. Nickols, Marisa M. Westlin, Sally Schroeter, Peter Ruminski	2004	66
7	Cartilage degradation biomarkers predict efficacy of a novel, highly selective matrix metalloproteinase 13 inhibitor in a dog model of osteoarthritis: Confirmation by multivariate analysis that modulation of type ii collagen and aggrecan degradation peptides parallels pathologic changes Arthritis & Rheumatism ·Steven L. Settle, Lillian E. Vickery, Olga V. Nemirovskiy, Tom J. Vidmar, Alison M. Bendele, Dean Messing, Peter Ruminski, Mark E. Schnute	2010	65
8	Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis Bioorganic & Medicinal Chemistry Letters ·Mark E. Schnute, Patrick O’Brien, Joe Nahra, Mark J. Morris, W. Howard Roark, Cathleen E. Hanau, Peter Ruminski, Jeffrey A. Scholten	2009	45
9	Pilot Plant Preparation of an α v β 3 Integrin Antagonist. Part 1. Process Research and Development of a ( S )-β-Amino Acid Ester Intermediate: Synthesis via a Scalable, Diastereoselective Imino-Reformatsky Reaction Organic Process Research & Development ·Jerry D. Clark, Gerald A. Weisenburger, D. Keith Anderson, Pierre-Jean Colson, Albert D. Edney, Donald J. Gallagher, H. Peter Kleine, Carl M. Knable	2003	38
10	Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells Journal of Clinical Investigation ·Darja Karpova, Michael P. Rettig, Julie Ritchey, Daniel Cancilla, Stephanie Christ, Leah Gehrs, Ezhilarasi Chendamarai, Moses O. Evbuomwan	2019	35
11	Evaluation of Aminohydantoins as a Novel Class of Antimalarial Agents ACS Medicinal Chemistry Letters ·Marvin J. Meyers, Micky Daniel Tortorella, Jing Xu, Limei Qin, Zhengxiang He, Xingfen Lang, Wentian Zeng, Wanwan Xu	2013	34
12	Insights into the role of the JAK/STAT signaling pathway in graft- versus -host disease Therapeutic Advances in Hematology ·Ramzi Abboud, Jaebok Choi, Peter Ruminski, Mark A. Schroeder, Sena Kim, Camille N. Abboud, John F. DiPersio	2020	34
13	Discovery ofN-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis Journal of Medicinal Chemistry ·Peter Ruminski, Mark A. Massa, Joseph W. Strohbach, Cathleen E. Hanau, Michelle A. Schmidt, Jeffrey A. Scholten, Theresa Fletcher, Bruce C. Hamper	2015	30
14	Cell Attachment and Spreading on Carbon Nanotubes Is Facilitated by Integrin Binding Frontiers in Bioengineering and Biotechnology ·Mozhdeh Imaninezhad, Joseph Martin Schober, David W. Griggs, Peter Ruminski, Irma Kuljanishvili, Silviya P. Zustiak	2018	29
15	Inhibitors of Arg-Gly-Asp-Binding Integrins Reduce Development of Pancreatic Fibrosis in Mice Cellular and Molecular Gastroenterology and Hepatology ·Barbara Ulmasov, Brent A. Neuschwander‐Tetri, Jinping Lai, Vladimir Monastyrskiy, Trisha S. Bhat, Matthew P. Yates, Jonathan Oliva, Michael J. Prinsen	2016	29
16	Synthesis of new verapamil analogues and their evaluation in combination with rifampicin against Mycobacterium tuberculosis and molecular docking studies in the binding site of efflux protein Rv1258c Bioorganic & Medicinal Chemistry Letters ·Kawaljit Singh, Malkeet Kumar, Elumalai Pavadai, Krupa Naran, Digby Francis Warner, Peter Ruminski, Kelly Chibale	2014	27
17	Evaluation of spiropiperidine hydantoins as a novel class of antimalarial agents Bioorganic & Medicinal Chemistry ·Marvin J. Meyers, Elizabeth J. Anderson, Sarah A. McNitt, Thomas M. Krenning, Megh Singh, Jing Xu, Wentian Zeng, Limei Qin	2015	25
18	Design, Synthesis, and Evaluation of Novel Hybrid Efflux Pump Inhibitors for Use against Mycobacterium tuberculosis ACS Infectious Diseases ·Malkeet Kumar, Kawaljit Singh, Krupa Naran, Fahreta Hamzabegovic, Daniel Fredric Hoft, Digby Francis Warner, Peter Ruminski, Getahun Abate	2016	19
19	Antibody-drug conjugates plus Janus kinase inhibitors enable MHC-mismatched allogeneic hematopoietic stem cell transplantation Journal of Clinical Investigation ·Stephen P. Persaud, Julie Ritchey, Sena Kim, Sora Lim, Peter Ruminski, Matthew L. Cooper, Michael P. Rettig, Jaebok Choi	2021	19
20	Synthesis of 1‐cyano‐2‐methylisoindole. A new route to isoindoles Journal of Heterocyclic Chemistry ·John J. D'Amico, B. R. STULTS, Peter Ruminski, Karl Vernon Wood	1983	19

About Peter Ruminski

Peter Ruminski is a scholar working on Immunology and Allergy, Hematology, Immunology, Organic Chemistry and Infectious Diseases, having authored 46 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (7 papers), Synthesis of heterocyclic compounds (6 papers), Hematopoietic Stem Cell Transplantation (6 papers), Synthesis and Characterization of Heterocyclic Compounds (5 papers), RNA Interference and Gene Delivery (4 papers), Immune Cell Function and Interaction (4 papers), Virus-based gene therapy research (4 papers) and Synthesis and Reactivity of Sulfur-Containing Compounds (4 papers). The work is most often cited by research in Immunology and Allergy (351 citations), Hepatology (244 citations), Immunology (655 citations), Oncology (414 citations) and Hematology (163 citations). Peter Ruminski has collaborated with scholars based in United States, United Kingdom and South Africa. Frequent co-authors include David W. Griggs, Michael J. Prinsen, Steven L. Settle, Christer Betsholtz, Antonella Pellicoro, Neil Cowan Henderson, Ralf H. Adams, Juan Duque Rodríguez, Jacquelyn J. Maher and Marilyn M. Giacomini. Their work appears in journals such as Blood, Bioorganic & Medicinal Chemistry, Journal of Clinical Investigation, Blood Advances and Organic Process Research & Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Peter Ruminski

Impact in

Papers in i

In The Last Decade

Peter Ruminski

Peter Ruminski's Hit Papers

Peers

Countries citing papers authored by Peter Ruminski

Fields of papers citing papers by Peter Ruminski

All Works

About Peter Ruminski

Explore authors with similar magnitude of impact

Papers in